Clinical Trial Update: Phase I/II Trial of Antagonism of HER in GI Cancer [Phase 2]

View source ↗

Summary

Phase II trial update on antagonism of HER in gastrointestinal cancer (metastatic/recurrent colorectal cancer) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: University College, London | Conditions: Metastatic Colorectal Cancer, Recurrent Colorectal Cancer | Phase 2 | Status: COMPLETED